APC clinical trials at UCSF
1 research study open to eligible people
APC refers to a gene possibly involved in cancer development. UCSF's clinical trials include testing a drug, FOG-001, for safety in serious cancer types. This study focuses on its potential effectiveness in treating locally advanced or metastatic tumors.
Showing trials for
FOG-001 in Locally Advanced or Metastatic Solid Tumors
open to eligible people ages 18 years and up
The goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced or metastatic cancer.
San Francisco, California and other locations
Last updated: